⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11878671 | 0.67 | — | — | |
| SCHEMBL12156692 | 0.65 | — | — | |
| SCHEMBL2254980 | 0.64 | — | — | |
| SCHEMBL24313202 | 0.64 | — | — | |
| SCHEMBL6693661 | 0.61 | — | — | |
| SCHEMBL8311981 | 0.61 | — | — | |
| SCHEMBL2154246 | 0.53 | — | — | |
| Hydrochloric Acid SCHEMBL28024752 | 0.50 | — | — | |
| SCHEMBL20636746 | 0.50 | — | — | |
| SCHEMBL49720 | 0.49 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240218051-A1 | MODIFIED BINDING POLYPEPTIDES FOR OPTIMIZED DRUG CONJUGATION | GENZYME CORPORATION | 2024-07-04 | — | — | US | disclosed |
| US-20240218051-A1 | MODIFIED BINDING POLYPEPTIDES FOR OPTIMIZED DRUG CONJUGATION | GENZYME CORPORATION | 2024-07-04 | — | — | US | disclosed |
| US-20180155827-A1 | Synthesis of Metal Nitride Thin Films Materials using Hydrazine Derivatives | APPLIED MATERIALS, INC. | 2018-06-07 | — | — | US | disclosed |
| US-20160136299-A1 | GLYCOENGINEERED ANTIBODY DRUG CONJUGATES | GENZYME CORPORATION | 2016-05-19 | — | — | US | disclosed |